acamprosate has been researched along with Clinically Isolated CNS Demyelinating Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cesario, A; Leung, YK; Munschauer, FE; Pankewycz, O; Rittenhouse-Olson, K; Sobel, RA; Sternberg, DS; Sternberg, Z; Whitcomb, T; Zhu, B | 1 |
1 other study(ies) available for acamprosate and Clinically Isolated CNS Demyelinating Syndrome
Article | Year |
---|---|
Acamprosate modulates experimental autoimmune encephalomyelitis.
Topics: Acamprosate; Animals; Blood-Brain Barrier; Body Weight; Demyelinating Diseases; Encephalomyelitis, Autoimmune, Experimental; Female; Inflammation; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Pilot Projects; Taurine; Tumor Necrosis Factor-alpha | 2012 |